Ultragenyx Pharmaceutical (RARE) EPS (Basic) Growth (1y) (2014 - 2026)
Ultragenyx Pharmaceutical (RARE) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.72 Bn | 2.31 Bn | 106.00 Mn | -17.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.27% |
| Dec 31, 2025 | 12.90% |
| Sep 30, 2025 | -29.33% |
| Jun 30, 2025 | 23.19% |
| Mar 31, 2025 | 22.56% |
| Dec 31, 2024 | 15.05% |
| Sep 30, 2024 | 37.24% |
| Jun 30, 2024 | 32.58% |
| Mar 31, 2024 | 13.10% |
| Dec 31, 2023 | 23.47% |
| Sep 30, 2023 | 36.33% |
| Jun 30, 2023 | 0.33% |
| Mar 31, 2023 | -6.35% |
| Dec 31, 2022 | -144.71% |
| Sep 30, 2022 | -225.33% |
| Jun 30, 2022 | -24.91% |
| Mar 31, 2022 | -8.00% |
| Dec 31, 2021 | 80.57% |
| Sep 30, 2021 | 5.20% |
| Jun 30, 2021 | -529.17% |